secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silence Therapeutics plc (SLN)
CIK:        0001479615
Form:       8-K
Filed at:   2026-08-12T21:23:33+00:00
Accession:  0001193125-26-347196
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silence Therapeutics prices $175M ADS offering at $13.50 per share
------------------------------------------------------------------

- Priced 12,962,963 ADSs at $13.50 each; gross proceeds ~$175M before expenses.
- Underwriters' 30-day option for up to 1,944,444 additional ADSs; net proceeds ~$164.0M (~$188.7M if option exercised).
- Closing expected Aug 13, 2026; Jefferies, Morgan Stanley, Cantor and William Blair act as joint book-runners.
- Underwriters purchase price $12.69 per ADS; offering under shelf registration on Form S-3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/0001193125-26-347196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479615/000119312526347196/d168365d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-347196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer